U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260188) titled 'Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy' on Nov. 14.
Brief Summary: The aim of this study is to establish patient-derived organoid (PDO) and tumor tissue cultures from breast cancer patients, in order to create personalized, accurate, and reliable preclinical models capable of providing information on the diverse biomolecular portraits of breast cancer. These models may also be used to predict the achievement of pathological complete response after neoadjuvant chemotherapy (NAC) treatment, study the biological, molecular, genetic, and microenvironmental characteristics of each tumor, and isolate tumor-d...